Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Matson Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Matson Inc trades at $225.67 (market cap $6.81B). The key difference: Iovance Biotherapeutics Inc. Common Stock and Matson Inc are close in size by market cap, and Matson Inc pays a 0.67% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Matson Inc for 23 Days on average.
| IOVA | MATX | |
|---|---|---|
Market Cap | $6.04B | $6.81B |
Volume | 14,805,993 | 255,080 |
Sector | Health | Industrials |
52-Week High | $14.82 | $238.60 |
52-Week Low | $1.81 | $88.05 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $5.97B | $7.41B |
Dividend Yield | — | 0.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Matson (MATX) trades at $225.67, up 1.23% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with Q2 2026 EPS of $4.27 beating estimates by 12.7% and raising full-year guidance. Revenue growth continues with 2026 projections of $3.5B and net profit margins above 13%. Recent institutional buying from Bank of New York Mellon and Deutsche Bank highlights confidence in the shipping company's prospects.
MATX presents a compelling investment case with strong earnings momentum, reasonable valuation (P/E 15.37), and positive analyst sentiment (67% buy ratings). Key risks include freight market cyclicality and competitive pressures. The stock's 27.3% upside potential based on analyst targets and consistent dividend payments ($0.38 declared for H2-26) support a favorable outlook for value-oriented investors seeking transportation sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
